Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Rep. Gilbert Ray Cisneros, Jr. disclosed purchasing $1,001–$15,000 of Cooper Companies shares on October 14, through a trust account.
• Cooper Companies reported quarterly EPS of $1.15, topping estimates of $1.12, while revenue of $1.07 billion fell short of expectations. The company also authorized a $3 billion share repurchase plan.
• Analysts have a consensus “Hold” rating and an average price target of $68.60; the shares were recently trading at $62.43.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on November 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cooper Companies stock on October 14th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of BridgeBio Pharma NASDAQ: BBIO on 11/2/2026.
• Purchased $1,001 - $15,000 in shares of argenex NASDAQ: ARGX on 10/27/2026.
• Sold $1,001 - $15,000 in shares of Illumina NASDAQ: ILMN on 10/27/2026.
• Sold $1,001 - $15,000 in shares of Revvity NYSE: RVTY on 10/27/2026.
• Sold $15,001 - $50,000 in shares of PTC NASDAQ: PTC on 10/27/2026.
• Purchased $1,001 - $15,000 in shares of BridgeBio Pharma NASDAQ: BBIO on 10/27/2026.
• Purchased $1,001 - $15,000 in shares of MACOM Technology Solutions NASDAQ: MTSI on 10/27/2026.
• Sold $1,001 - $15,000 in shares of Micron Solutions OTCMKTS: MICR on 10/21/2026.
• Sold $1,001 - $15,000 in shares of Ciena NYSE: CIEN on 10/21/2026.
• Purchased $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 10/21/2026.

Cooper Companies Trading Down 0.8%

NASDAQ COO traded down $0.50 during trading hours on Thursday, reaching $62.43. The company's stock had a trading volume of 260,142 shares, compared to its average volume of 2,711,905. The stock has a market cap of $11.87 billion, a P/E ratio of 21.33, a P/E/G ratio of 2.50 and a beta of 0.83. The Cooper Companies, Inc. has a 52 week low of $51.01 and a 52 week high of $89.83. The firm has a fifty day simple moving average of $58.80 and a 200-day simple moving average of $68.33. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.03. The company had revenue of $1.07 billion during the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The business's quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.

Cooper Companies declared that its board has initiated a stock buyback plan on Wednesday, September 9th that permits the company to repurchase $3 billion in outstanding shares. This repurchase authorization permits the medical device company to repurchase up to 22.7% of its shares through open market purchases. Share repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

Institutional Trading of Cooper Companies

Several institutional investors and hedge funds have recently modified their holdings of the business. Avalon Trust Co bought a new position in shares of Cooper Companies in the second quarter worth approximately $25,000. Elevation Wealth Partners LLC grew its stake in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after buying an additional 375 shares in the last quarter. Continuum Advisory LLC purchased a new position in Cooper Companies in the 2nd quarter worth approximately $30,000. Jacobi Capital Management LLC purchased a new position in Cooper Companies in the 3rd quarter worth approximately $25,000. Finally, J.Safra Asset Management Corp bought a new position in shares of Cooper Companies in the 2nd quarter worth $32,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insider Transactions at Cooper Companies

In related news, Director Paul Keel acquired 4,701 shares of the stock in a transaction dated Friday, September 11th. The shares were purchased at an average price of $53.18 per share, for a total transaction of $249,999.18. Following the transaction, the director owned 4,701 shares in the company, valued at $249,999.18. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Lawrence Kurzius acquired 10,000 shares of the company's stock in a transaction dated Monday, September 14th. The shares were bought at an average cost of $53.91 per share, with a total value of $539,100.00. Following the completion of the acquisition, the director directly owned 21,099 shares in the company, valued at $1,137,447.09. The trade was a 90.10% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 34,701 shares of company stock valued at $1,880,039 in the last quarter. Insiders own 2.08% of the company's stock.

Analysts Set New Price Targets

A number of analysts have commented on COO shares. Citigroup reissued a "neutral" rating and set a $60.00 price objective (down from $80.00) on shares of Cooper Companies in a report on Thursday, September 10th. William Blair downgraded Cooper Companies from an "outperform" rating to a "market perform" rating in a research report on Thursday, September 10th. Wall Street Zen cut Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, September 12th. Wells Fargo & Company set a $61.00 price objective on shares of Cooper Companies and gave the company an "equal weight" rating in a research note on Thursday, September 10th. Finally, Weiss Ratings lowered shares of Cooper Companies from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, October 28th. Four research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $68.60.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Cooper Companies

CooperCompanies is a global medical device company focused on vision care and women's health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women's health and fertility care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.